Clinical Trial Update: Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy of metronomic capecitabine in triple-negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED